Company Overview and News

 
Apar Industries Limited - Updates

2018-09-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Check out insider trades for Sept 3; IDFC Bank, LT Finance Tech Mahindra in focus

2018-09-05 moneycontrol
Trident: Trident Group Ltd. (Old Name: Madhuraj Foundation Ltd.) (promoter) bought 15,50,000 shares through market purchase on August 31, 2018
GRUH APARINDS KMBKY RAJTV 532826 GRHFY TCHQY 532755 532259 511288 TECHM 539437 IDFCBANK KOTAKBANK 500247

 
Apar Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-09-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Apar Industries Limited - Resignation

2018-08-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Apar Industries touches 52-week low on weak June quarter numbers

2018-08-09 moneycontrol
Shares of Apar Industries touched 52-week low of Rs 575, down 4.8 percent intraday Thursday on the back of weak Q1FY19 (April-June) numbers.
APARINDS 532259

 
Apar Industries Limited - Outcome of Board Meeting

2018-08-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Apar Industries Limited - Financial Result Updates

2018-08-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Apar Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Apar Industries Limited - Shareholders meeting

2018-07-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Apar Industries Limited - AGM/Book Closure

2018-07-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
APARINDS 532259

 
Atlan Holdings, Rohas Tecnic, N2N Connect, Adventa, Top Glove, Versatile Creative, LPI Capital and Econpile

2018-07-09 theedgemarkets
KUALA LUMPUR (July 9): Based on corporate announcements and news flow today, stocks that will draw some attention on Tuesday (July 10) may include: Atlan Holdings, Rohas Tecnic, N2N Connect, Adventa, Top Glove, Versatile Creative, LPI Capital and Econpile.
TGLVY 4995 APARINDS 0108 8621 7113 5253 TPGVF 5SO BSMAF 532259 1818

 
Rohas Tecnic JV wins RM37.8 mil transmission lines reconductoring contract

2018-07-09 theedgemarkets
KUALA LUMPUR (July 9): Rohas Tecnic Bhd has bagged a joint-venture contract for the reconductoring of three existing transmission lines for a combination of US$7.52 million and 157.73 million Bangladeshi Taka (about RM37.8 million).
APARINDS 532259

8
Podcast | A morning walk down Dalal Street: Stay cautious as long as Nifty trades below 10,700

2018-07-03 moneycontrol
D-Street witnessed a smart recovery in the second half of the session on Monday but it failed to close above 10,700 levels. The index closed below its crucial short-term moving averages such as 5-EMA, 13-EMA as well as 50-EMA in a single session.
BAJAJ-AUTO 500408 APARINDS 500116 DALMIABHA IDBI FORCEMOT 532977 SRTRANSFIN 532259 511218 FINOLEXIND 533309 SRRQY TATAELXSI 500940 500570 TATAMOTORS 500033 TTM

37
Podcast | An evening walk down Dalal Street: Sensex falls over 150 points; nearly 300 stocks hit 52-week low

2018-07-02 moneycontrol
The S&P BSE Sensex reversed half of Friday's gains to end the first session of the week lower by half a percent on Monday, dragged by global weakness due to trade tensions and political uncertainty in Germany.
BAJAJ-AUTO 500820 532938 KAJARIACER CAPF 532977 BHRQY ASIANPAINT 533278 532259 532343 500470 533309 500233 LNSTY HDFCBANK HEROMOTOCO 500477 BHARTIARTL CLNDY 509488 500033 ASHOKLEY APARINDS TVSMOTOR GRAPHITE DALMIABHA IBN FORCEMOT AKLD 500182 FINOLEXIND 532454 ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 500940 HRTQY AKLS COALINDIA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...